Streetbeat News

Regulatory

MYGN

Myriad Genetics announced that the US Patent and Trademark Office has granted a patent covering the use of push-button blood collection devices for PCR-based fetal sex determination. The patent, U.S. Patent No. 11,932,907, titled 'Fetal Sex Determination Using Capillary Blood From Upper Arm,' protects Myriad's SneakPeek Snap products in the U.S through 2040.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 8:08 pm

PLTR

Palantir Technologies Inc (NYSE:PLTR) shares rose 3.2% to $24.55 after the Federal Reserve decided to keep interest rates steady at 5.25-5.5%. The Fed's future plans include three rate cuts in 2024, aiming for a 4.6% target. This decision and the optimistic economic growth projections for 2024 suggest a favorable environment for Palantir's expansion and growth, potentially boosting its stock price.

Portfolio Pulse from Henry Khederian

March 20, 2024 | 8:06 pm

PLUG

Plug Power Inc (NASDAQ:PLUG) shares surged 9.4% to $3.56 after the Federal Reserve decided to keep interest rates steady, with projections indicating potential rate cuts in 2024. This decision is seen as beneficial for the broader economy and companies like Plug Power, which may experience increased demand for its green energy and fuel cell technology products as economic conditions improve.

Portfolio Pulse from Henry Khederian

March 20, 2024 | 8:02 pm

TOVX

Theriva Biologics has been granted an EU patent (#3292142) for its innovative approach to cancer treatment using oncolytic adenoviruses with mutations in immunodominant adenovirus epitopes. This patent represents a significant advancement in the field of cancer therapy, potentially offering new treatment options for patients.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 8:01 pm

GLD

QQQ

SPY

TLT

Fed Chair Jerome Powell indicated potential rate cuts later this year, emphasizing a cautious approach based on economic conditions. The S&P 500 and Nasdaq 100 rose to all-time highs, while Treasury yields remained flat. Powell's comments on inflation and economic growth projections were balanced, suggesting readiness for both maintaining and adjusting rates as needed.

Portfolio Pulse from Piero Cingari

March 20, 2024 | 7:57 pm

Fort shares are trading higher due to reports that Biden's new rule on auto emissions could boost EV sales, alongside overall market strength after the Fed left rates unchanged.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 7:38 pm

TSLA

Tesla shares are experiencing an uptick following reports that President Biden's new auto emissions rule could potentially increase electric vehicle (EV) sales. Additionally, the stock's rise is supported by the overall market strength, which has been buoyed by the Federal Reserve's decision to leave interest rates unchanged.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 7:38 pm

ALLY

AXP

BAM

Shares of companies in the financial services sector are trading higher following the Federal Reserve's decision to leave interest rates unchanged.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 7:29 pm

ANET

APP

ARM

AUR

ENPH

LITE

MSTR

NET

PLTR

PSTG

SEDG

SHOP

SNOW

TER

WOLF

Shares of technology companies are up following the Federal Reserve's decision to leave interest rates unchanged, indicating overall market strength.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 7:26 pm

AQST

ETAO

LFCR

SIG

TRUG

XTLB

U.S. stocks rose after the Federal Reserve left interest rates unchanged, with the Dow, NASDAQ, and S&P 500 all posting gains. Industrials and health care sectors saw mixed performance. Several companies experienced significant stock movements, including ETAO International, XTL Biopharmaceuticals, and TruGolf Holdings seeing sharp increases, while Lifecore Biomedical, Aquestive Therapeutics, and Signet Jewelers reported declines. The Fed's decision to maintain rates between 5.25% and 5.5% was anticipated, aligning with investor expectations.

Portfolio Pulse from Avi Kapoor

March 20, 2024 | 7:22 pm